MAR 09, 2016 5:30 PM PST

Can epigenetics make better cancer drugs?

Natural killer cells that can kill and contain viruses and cancerous tumors can be manipulated by epigenetics, a finding that paves the way for developing more effective cancer drugs.
 
Understanding how a new enzyme affects natural killer cells may eventually help make cancer drugs more effective, but scientists don't yet have enough information about their molecular makeup to use them in the laboratory.

“Natural killer cells are very attractive targets for immunotherapy because they are able to kill tumor cells,” says Si-Yi Chen, professor of molecular microbiology and immunology at the Keck School of Medicine at the University of Southern California.

“While scientists all around the world are working on developing new drugs using NK cells, none of the drugs in development focuses on epigenetic regulation of the cells.”

“Our study describes how an epigenetic process involving the enzyme MYSM1 plays a critical role in the development of natural killer cells.”

Epigenetics involve biochemical changes in the body that directly affect DNA, turning some genes on and turning others off. MYSM1 is an enzyme in the body’s immune system that turns genes on and off by modifying proteins called histones embedded in DNA.

For a study published in Proceedings of the National Academy of Sciences, Chen and colleagues used mice to demonstrate that MYSM1 is required for natural killer cells to mature and function properly.

“We found that MYSM1 creates access to proteins that enhance gene transcription and, ultimately, the maturation of natural killer cells themselves,” says Ph.D. student Vijayalakshmi Nandakumar, the study’s first author.

“To date, there are no elaborate reports linking an epigenetic phenomenon to natural killer cell development. More importantly, unlike conventional therapies, NK cell-based therapies have shown to be more effective against metastasis.

“We believe cancer drugs targeting this pathway could be a viable option for future immunotherapies.”

The National Institutes of Health and a Leukemia & Lymphoma Society Specialized Center of Research Award supported the research.

Source: USC

This article was originally posted on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
AUG 27, 2020
Space & Astronomy
Space Rock May Contain Building Blocks for DNA
AUG 27, 2020
Space Rock May Contain Building Blocks for DNA
Researchers say that a space rock that landed in Costa Rica on April 23rd, 2019, came from an asteroid that exists as a ...
SEP 28, 2020
Genetics & Genomics
Why Some Young, Healthy People Get Severe COVID-19
SEP 28, 2020
Why Some Young, Healthy People Get Severe COVID-19
Since the start of the pandemic, scientists have been trying to find out why some people get such severe illness from SA ...
OCT 27, 2020
Immunology
The Genetics of Skin Inflammation, Seen With Unprecedented Clarity
OCT 27, 2020
The Genetics of Skin Inflammation, Seen With Unprecedented Clarity
A recent study published in Immunity details MIT scientists’ exploration of the underlying mechanisms of inflammat ...
OCT 24, 2020
Genetics & Genomics
Cord Blood Samples Reveal More About the Genetics of Autism
OCT 24, 2020
Cord Blood Samples Reveal More About the Genetics of Autism
The activity of genes in our genome is controlled by many factors, one of which are chemical tags or structural changes ...
NOV 10, 2020
Immunology
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
NOV 10, 2020
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
In the middle of 2020, yet another deadly Ebola outbreak was reported in the Democratic Republic of the Congo - the 11th ...
NOV 23, 2020
Genetics & Genomics
Unusual Mutation Acts as a Kind of Gene Therapy
NOV 23, 2020
Unusual Mutation Acts as a Kind of Gene Therapy
Clinicians have identified a patient with a rare inherited disorder that disrupts the production of fresh blood cells, a ...
Loading Comments...